Skip to content
Certified ManufacturersFor manufacturers

Alfa Vitamins Laboratories, Inc.

Miami, FL, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Alfa Vitamins Laboratories, Inc. is a dietary supplement manufacturer in Miami, FL, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, gummies, liquids, softgels and tablets.

Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • 4701 NW 77th Avenue, Miami, FL 33166, United States

    • Coating
    • Encapsulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Pasteurization
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing

How Alfa Vitamins Laboratories, Inc. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

FDA lists 1 recall matching the name Alfa Vitamins Laboratories, Inc., as of .

  • Class III · Unlikely to cause health problems

    Reported

    Closed by FDA

    FDA sample analysis of Calci-Max lot 31453 showed the product zinc content to be 0.0% of label claim.

    Product: CALCI-MAX Dietary Supplement, 60 capsules, Manufactured for: DOMEL

    openFDA record

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 6 food or dietary supplement inspections at facilities matching Alfa Vitamins Laboratories, Inc., from 2013 to 2026, as of . All 6 found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    5 citations posted:

    • Equipment - follow written procedures (21 CFR 111.25)
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Quality control operations - finished batch, specifications (21 CFR 111.123(a)(7))
    • Written procedures - establish; laboratory (21 CFR 111.303)
    See all 5 citations
    • Equipment - follow written procedures (21 CFR 111.25)

      You did not follow written procedures for fulfilling the requirements for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for strength.

    • Quality control operations - finished batch, specifications (21 CFR 111.123(a)(7))

      Your quality control operations did not include determining whether each finished batch conforms to established product specifications.

    • Written procedures - establish; laboratory (21 CFR 111.303)

      You did not establish written procedures for laboratory operations.

    • Make and keep records - laboratory operations (21 CFR 111.325(b))

      You did not make and keep records for your laboratory operations.

    FEI 3005570707

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    8 citations posted:

    • Cleaning compounds and toxic materials - holding (21 CFR 111.15(c)(3))
    • Hand-washing facilities (21 CFR 111.15(i))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    See all 8 citations
    • Cleaning compounds and toxic materials - holding (21 CFR 111.15(c)(3))

      You did not identify and hold cleaning compounds, sanitizing agents, pesticides, pesticide chemicals, or other toxic materials in a manner that protects against contamination of components, dietary supplements, or contact surfaces.

    • Hand-washing facilities (21 CFR 111.15(i))

      Your hand-washing facilities are not adequate and do not furnish running water at a suitable temperature.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the strength and composition of the finished dietary supplement.

    • Master manufacturing record - each batch (21 CFR 111.205(a))

      You did not prepare and follow a written master manufacturing record for each batch size of a dietary supplement that you manufactured.

    • Packaging description, representative label (21 CFR 111.210(g))

      Your master manufacturing record did not include a representative label, or a cross-reference to the physical location of the actual or representative label.

    • Written procedures - laboratory operations (21 CFR 111.303)

      You did not follow written procedures for laboratory operations.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold components and dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    FEI 3005570707

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    5 citations posted:

    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Sanitation supervisors - assigned (21 CFR 111.15(k))
    • Master manufacturing record - intentional overage (21 CFR 111.210(e))
    • Written procedures - laboratory operations (21 CFR 111.303)
    See all 5 citations
    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in manufacturing, packaging, labeling and holding dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Sanitation supervisors - assigned (21 CFR 111.15(k))

      You did not assign one or more employees to supervise overall sanitation.

    • Master manufacturing record - intentional overage (21 CFR 111.210(e))

      Your master manufacturing record did not include a statement of intentional overage amount of a dietary ingredient.

    • Written procedures - laboratory operations (21 CFR 111.303)

      You did not follow written procedures for laboratory operations.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold components and dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    FEI 3005570707

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    11 citations posted:

    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Pest control measures (21 CFR 111.15(d)(2))
    • Procedures - calibrating instruments (21 CFR 111.25(a))
    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
    See all 11 citations
    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in manufacturing, packaging, labeling and holding dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Pest control measures (21 CFR 111.15(d)(2))

      You did not take effective measures to exclude pests from the physical plant.

    • Procedures - calibrating instruments (21 CFR 111.25(a))

      You did not follow written procedures for calibrating instruments and controls that you use in manufacturing or testing a component or dietary supplement.

    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))

      You did not follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.

    • Equipment - automated - suitability (21 CFR 111.30(b))

      You did not determine the suitability of the automated, mechanical, or electronic equipment by ensuring that the equipment is capable of operating satisfactorily within the operating limits required by the process.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for purity, strength and composition.

    • Quality control operations - master, batch, manufacturing (21 CFR 111.123)

      You do not have quality control operations required for the master manufacturing record, batch production record and manufacturing operations.

    • Master manufacturing record - unique formulation (21 CFR 111.205(a))

      You did not prepare and follow a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

    • Written procedures - holding (21 CFR 111.453)

      You did not follow written procedures for holding and distributing operations.

    • HACCP plan - verify procedures / frequency - none listed (21 CFR 120.8(b)(6))

      Your HACCP plan does not list the verification procedures and frequencies that have been developed to ensure that the HACCP plan is being implemented.

    FEI 3005570707

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    17 citations posted:

    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Equipment - design - suitable (21 CFR 111.27(a))
    • Specifications - manufacturing process (21 CFR 111.70(a))
    • Specifications - component identity (21 CFR 111.70(b)(1))
    See all 17 citations
    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in labeling and holding dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Equipment - design - suitable (21 CFR 111.27(a))

      You did not use equipment or utensils of appropriate design, construction, and workmanship to enable them to be suitable for its intended use.

    • Specifications - manufacturing process (21 CFR 111.70(a))

      You did not establish a specification for a point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.

    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Reserve sample - twice the quantity (21 CFR 111.83(b)(4))

      Your reserve sample did not consist of at least twice the quantity necessary for all tests or examinations to determine whether or not the dietary supplement meets product specifications.

    • Written procedure quality control operations material review (21 CFR 111.103)

      You did not establish and follow written procedures for quality control operations for conducting a material review and making a disposition decision.

    • Written procedures - quality control operations (21 CFR 111.103)

      You did not establish and follow written procedures for quality control operations.

    • Components - quarantine (21 CFR 111.155(c))

      You did not quarantine components before you used them in the manufacture of a dietary supplement.

    • Master manufacturing record - each batch (21 CFR 111.205(a))

      You did not prepare and follow a written master manufacturing record for each batch size of a dietary supplement that you manufactured.

    • Master manufacturing record - unique formulation (21 CFR 111.205(a))

      You did not prepare and follow a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

    • Batch record - complete (21 CFR 111.255(b))

      Your batch production record did not include complete information relating to the production and control of each batch.

    • Written procedures - labeling operations (21 CFR 111.403)

      You did not establish and follow written procedures for labeling operations.

    • Written procedures - holding (21 CFR 111.453)

      You did not establish and follow written procedures for holding and distributing operations.

    • Written procedures - returned dietary supplement; destroyed (21 CFR 111.503)

      You did not establish and follow written procedures for when a returned dietary supplement must be destroyed, or otherwise suitably disposed.

    • Records - returned dietary supplement: written procedures (21 CFR 111.535(b)(1))

      You did not make and keep records of written procedures for fulfilling requirements for returned dietary supplements.

    • Written procedures - product complaint (21 CFR 111.553)

      You did not establish and follow written procedures for the requirements to review and investigate a product complaint.

    • Written procedures - product complaint; review, investigate (21 CFR 111.570(b)(1))

      You did not make and keep written procedures to fulfill the requirements that apply to the review and investigation of a product complaint.

    FEI 3005570707

Show all 6 inspections
  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    5 citations posted:

    • Equipment - follow written procedures (21 CFR 111.25)
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Quality control operations - finished batch, specifications (21 CFR 111.123(a)(7))
    • Written procedures - establish; laboratory (21 CFR 111.303)
    See all 5 citations
    • Equipment - follow written procedures (21 CFR 111.25)

      You did not follow written procedures for fulfilling the requirements for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for strength.

    • Quality control operations - finished batch, specifications (21 CFR 111.123(a)(7))

      Your quality control operations did not include determining whether each finished batch conforms to established product specifications.

    • Written procedures - establish; laboratory (21 CFR 111.303)

      You did not establish written procedures for laboratory operations.

    • Make and keep records - laboratory operations (21 CFR 111.325(b))

      You did not make and keep records for your laboratory operations.

    FEI 3005570707

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    8 citations posted:

    • Cleaning compounds and toxic materials - holding (21 CFR 111.15(c)(3))
    • Hand-washing facilities (21 CFR 111.15(i))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    See all 8 citations
    • Cleaning compounds and toxic materials - holding (21 CFR 111.15(c)(3))

      You did not identify and hold cleaning compounds, sanitizing agents, pesticides, pesticide chemicals, or other toxic materials in a manner that protects against contamination of components, dietary supplements, or contact surfaces.

    • Hand-washing facilities (21 CFR 111.15(i))

      Your hand-washing facilities are not adequate and do not furnish running water at a suitable temperature.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the strength and composition of the finished dietary supplement.

    • Master manufacturing record - each batch (21 CFR 111.205(a))

      You did not prepare and follow a written master manufacturing record for each batch size of a dietary supplement that you manufactured.

    • Packaging description, representative label (21 CFR 111.210(g))

      Your master manufacturing record did not include a representative label, or a cross-reference to the physical location of the actual or representative label.

    • Written procedures - laboratory operations (21 CFR 111.303)

      You did not follow written procedures for laboratory operations.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold components and dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    FEI 3005570707

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    5 citations posted:

    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Sanitation supervisors - assigned (21 CFR 111.15(k))
    • Master manufacturing record - intentional overage (21 CFR 111.210(e))
    • Written procedures - laboratory operations (21 CFR 111.303)
    See all 5 citations
    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in manufacturing, packaging, labeling and holding dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Sanitation supervisors - assigned (21 CFR 111.15(k))

      You did not assign one or more employees to supervise overall sanitation.

    • Master manufacturing record - intentional overage (21 CFR 111.210(e))

      Your master manufacturing record did not include a statement of intentional overage amount of a dietary ingredient.

    • Written procedures - laboratory operations (21 CFR 111.303)

      You did not follow written procedures for laboratory operations.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold components and dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    FEI 3005570707

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    11 citations posted:

    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Pest control measures (21 CFR 111.15(d)(2))
    • Procedures - calibrating instruments (21 CFR 111.25(a))
    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
    See all 11 citations
    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in manufacturing, packaging, labeling and holding dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Pest control measures (21 CFR 111.15(d)(2))

      You did not take effective measures to exclude pests from the physical plant.

    • Procedures - calibrating instruments (21 CFR 111.25(a))

      You did not follow written procedures for calibrating instruments and controls that you use in manufacturing or testing a component or dietary supplement.

    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))

      You did not follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.

    • Equipment - automated - suitability (21 CFR 111.30(b))

      You did not determine the suitability of the automated, mechanical, or electronic equipment by ensuring that the equipment is capable of operating satisfactorily within the operating limits required by the process.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for purity, strength and composition.

    • Quality control operations - master, batch, manufacturing (21 CFR 111.123)

      You do not have quality control operations required for the master manufacturing record, batch production record and manufacturing operations.

    • Master manufacturing record - unique formulation (21 CFR 111.205(a))

      You did not prepare and follow a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

    • Written procedures - holding (21 CFR 111.453)

      You did not follow written procedures for holding and distributing operations.

    • HACCP plan - verify procedures / frequency - none listed (21 CFR 120.8(b)(6))

      Your HACCP plan does not list the verification procedures and frequencies that have been developed to ensure that the HACCP plan is being implemented.

    FEI 3005570707

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    17 citations posted:

    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Equipment - design - suitable (21 CFR 111.27(a))
    • Specifications - manufacturing process (21 CFR 111.70(a))
    • Specifications - component identity (21 CFR 111.70(b)(1))
    See all 17 citations
    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in labeling and holding dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Equipment - design - suitable (21 CFR 111.27(a))

      You did not use equipment or utensils of appropriate design, construction, and workmanship to enable them to be suitable for its intended use.

    • Specifications - manufacturing process (21 CFR 111.70(a))

      You did not establish a specification for a point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.

    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Reserve sample - twice the quantity (21 CFR 111.83(b)(4))

      Your reserve sample did not consist of at least twice the quantity necessary for all tests or examinations to determine whether or not the dietary supplement meets product specifications.

    • Written procedure quality control operations material review (21 CFR 111.103)

      You did not establish and follow written procedures for quality control operations for conducting a material review and making a disposition decision.

    • Written procedures - quality control operations (21 CFR 111.103)

      You did not establish and follow written procedures for quality control operations.

    • Components - quarantine (21 CFR 111.155(c))

      You did not quarantine components before you used them in the manufacture of a dietary supplement.

    • Master manufacturing record - each batch (21 CFR 111.205(a))

      You did not prepare and follow a written master manufacturing record for each batch size of a dietary supplement that you manufactured.

    • Master manufacturing record - unique formulation (21 CFR 111.205(a))

      You did not prepare and follow a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

    • Batch record - complete (21 CFR 111.255(b))

      Your batch production record did not include complete information relating to the production and control of each batch.

    • Written procedures - labeling operations (21 CFR 111.403)

      You did not establish and follow written procedures for labeling operations.

    • Written procedures - holding (21 CFR 111.453)

      You did not establish and follow written procedures for holding and distributing operations.

    • Written procedures - returned dietary supplement; destroyed (21 CFR 111.503)

      You did not establish and follow written procedures for when a returned dietary supplement must be destroyed, or otherwise suitably disposed.

    • Records - returned dietary supplement: written procedures (21 CFR 111.535(b)(1))

      You did not make and keep records of written procedures for fulfilling requirements for returned dietary supplements.

    • Written procedures - product complaint (21 CFR 111.553)

      You did not establish and follow written procedures for the requirements to review and investigate a product complaint.

    • Written procedures - product complaint; review, investigate (21 CFR 111.570(b)(1))

      You did not make and keep written procedures to fulfill the requirements that apply to the review and investigation of a product complaint.

    FEI 3005570707

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami, Florida

    20 citations posted:

    • Hair restraints (21 CFR 111.10(b)(6))
    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
    • Equipment - design - suitable (21 CFR 111.27(a))
    See all 20 citations
    • Hair restraints (21 CFR 111.10(b)(6))

      Your personnel did not wear effective hair restraints in an effective manner.

    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in manufacturing, packaging, labeling, and holding dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))

      You did not follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.

    • Equipment - design - suitable (21 CFR 111.27(a))

      You did not use equipment or utensils of appropriate design, construction, and workmanship to enable them to be suitable for its intended use, adequately cleaned, and properly maintained.

    • Equipment - automated - suitability (21 CFR 111.30(b))

      You did not determine the suitability of the automated, mechanical, or electronic equipment by ensuring that the equipment is capable of operating satisfactorily within the operating limits required by the process.

    • Records - backup files, outdated software (21 CFR 111.35(b)(5))

      You did not make and keep backup files of outdated software necessary to retrieve records from the computer systems that you use to manufacture, package, label, or hold dietary supplements.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength, and composition.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, composition, and limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement.

    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))

      Your quality control personnel did not reject a component and dietary supplement when an established specification was not met.

    • Quality control operations - quarantine (21 CFR 111.120(e))

      Your quality control operations did not include approving, and releasing from quarantine, all packaging and labels before they were used.

    • Quality control - finished batch, distribution (21 CFR 111.123(a)(8))

      Your quality control operations did not include approving and releasing, or rejecting, each finished batch for distribution.

    • Quality control operations - product complaints; investigate (21 CFR 111.135)

      Your quality control operations for product complaints did not include reviewing and approving decisions about whether to investigate a product complaint and reviewing and approving the findings and follow-up action of any investigation performed.

    • Components - quarantine (21 CFR 111.155(c))

      You did not quarantine components before you used them in the manufacture of a dietary supplement.

    • Components - representative samples (21 CFR 111.155(c)(1))

      You did not collect representative samples of components while the components were quarantined.

    • Master manufacturing record - each batch (21 CFR 111.205(a))

      You did not prepare a written master manufacturing record for each batch size of a dietary supplement that you manufactured.

    • Batch record - complete (21 CFR 111.255(b))

      Your batch production record did not include complete information relating to the production and control of each batch.

    • Batch record - packaging, labeling (21 CFR 111.260(k))

      Your batch production records did not include documentation, at the time of performance, of packaging and labeling operations.

    • Hold, identify - in-process material (21 CFR 111.460(a))

      You did not identify and hold in-process material under conditions that protect against mix-up, contamination, or deterioration.

    FEI 3005570707

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 1 facility address
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other gummy manufacturers in the United States

  1. NSF lists 4 gummy facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a gummy facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists 2 gummy facilities, including one in St. Augustine, FL

    St. Augustine, FL, United Statesactivegummy.com

    • Gummies
    Operations:
    • Molding
    • Coating
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a gummy facility in Merrilville, IN

    Merrilville, IN, United Statesalbanesecandy.com

    • Gummies
    Operations:
    • Molding
    • Liquid formulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists a gummy facility in Dallas, TX

    Dallas, TX, United Statesforeverliving.com

    • Gummies
    • Liquids
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Liquid formulation
    • Tablet compression
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a gummy facility in Ontario, CA

    Ontario, CA, United Statesalphaplustech.us

    • Capsules
    • Gummies
    • Liquids
    • Oils
    • Powders
    • Softgels
    • +1 more
    Operations:
    • Liquid formulation
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026